Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat

被引：193

作者：

Daša Čížková ^{[1
]}

Ján Rosocha ^{[4
]}

Ivo Vanický ^{[2
]}

Stanislava Jergová ^{[1
]}

Milan Čížek ^{[1
]}

机构：

[1] Institute of Neurobiology, Center of Excellence, SAS, Košice 04001

[2] Faculty of Medicine, University Hospital, P.J. Šafárik University, Košice 04011

[3] UVM, Košice

来源：

Cellular and Molecular Neurobiology | 2006年 / 26卷 / 7期

关键词：

Cell therapy; Mesenchymal stem cells; Regeneration; Spinal cord trauma;

D O I：

10.1007/s10571-006-9093-1

中图分类号：

学科分类号：

摘要：

Human mesenchymal stem cells (hMSCs) derived from adult bone marrow represent a potentially useful source of cells for cell replacement therapy after nervous tissue damage. They can be expanded in culture and reintroduced into patients as autografts or allografts with unique immunologic properties. The aim of the present study was to investigate (i) survival, migration, differentiation properties of hMSCs transplanted into non-immunosuppressed rats after spinal cord injury (SCI) and (ii) impact of hMSC transplantation on functional recovery. Seven days after SCI, rats received i.v. injection of hMSCs (2×106 in 0.5 mL DMEM) isolated from adult healthy donors. Functional recovery was assessed by Basso-Beattie-Bresnahan (BBB) score weekly for 28 days. Our results showed gradual improvement of locomotor function in transplanted rats with statistically significant differences at 21 and 28 days. Immunocytochemical analysis using human nuclei (NUMA) and BrdU antibodies confirmed survival and migration of hMSCs into the injury site. Transplanted cells were found to infiltrate mainly into the ventrolateral white matter tracts, spreading also to adjacent segments located rostro-caudaly to the injury epicenter. In double-stained preparations, hMSCs were found to differentiate into oligodendrocytes (APC), but not into cells expressing neuronal markers (NeuN). Accumulation of GAP-43 regrowing axons within damaged white matter tracts after transplantation was observed. Our findings indicate that hMSCs may facilitate recovery from spinal cord injury by remyelinating spared white matter tracts and/or by enhancing axonal growth. In addition, low immunogenicity of hMSCs was confirmed by survival of donor cells without immunosuppressive treatment. © 2006 Springer Science+Business Media, Inc.

引用

页码：1167 / 1180

页数：13

共 46 条

[1]

Aggarwal S., Pittenger M.F., Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, pp. 1815-1822, (2005)

[2]

Akiyama Y., Radtke C., Honmou O., Kocsis J.D., Remyelination of the spinal cord following intravenous delivery of bone marrow cells, Glia, 39, pp. 229-236, (2002)

[3]

Ankeny D.P., McTigue D.M., Jakeman L.B., Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats, Exp. Neurol., 190, pp. 17-31, (2004)

[4]

Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., Rovner A., Ellis S.G., Thomas J.D., DiCorleto P.E., Topol E.J., Penn M.S., Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy, Lancet, 362, pp. 697-703, (2003)

[5]

Cizkova D., Racekova E., Vanicky I., The expression of B-50/GAP-43 and GFAP after bilateral olfactory bulbectomy in rats, Physiol. Res., 46, pp. 487-495, (1997)

[6]

Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M., Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, pp. 3838-3843, (2002)

[7]

Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., Mulligan R.C., Dystrophin expression in the mdx mouse restored by stem cell transplantation, Nature, 401, pp. 390-394, (1999)

[8]

Hamano K., Li T.S., Kobayashi T., Kobayashi S., Matsuzaki M., Esato K., Angiogenesis induced by the implantation of self-bone marrow cells: A new material for therapeutic angiogenesis, Cell Transplant., 9, pp. 439-443, (2000)

[9]

Hofstetter C.P., Schwarz E.J., Hess D., Widenfalk J., El Manira A., Prockop D.J., Olson L., Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery, Proc. Natl. Acad. Sci. U.S.A., 99, pp. 2199-2204, (2002)

[10]

Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., Chopp M., Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats, Circ. Res., 92, pp. 692-699, (2003)

← 1 2 3 4 5 →